Mersana Therapeutics Statistics

Total Valuation

MRSN has a market cap or net worth of $33.95 million. The enterprise value is -$43.71 million.

Market Cap	33.95M
Enterprise Value	-43.71M

Important Dates

The last earnings date was Wednesday, August 13, 2025, before market open.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

MRSN has 4.99 million shares outstanding. The number of shares has increased by 2.12% in one year.

Current Share Class	4.99M
Shares Outstanding	4.99M
Shares Change (YoY)	+2.12%
Shares Change (QoQ)	+0.16%
Owned by Insiders (%)	1.97%
Owned by Institutions (%)	39.10%
Float	3.75M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.97
Forward PS	1.43
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-18.58

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-256.18%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	$340,873
Profits Per Employee	-$725,853
Employee Count	102
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, MRSN has paid $418,000 in taxes.

Income Tax	418,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -80.82% in the last 52 weeks. The beta is 0.82, so MRSN's price volatility has been lower than the market average.

Beta (5Y)	0.82
52-Week Price Change	-80.82%
50-Day Moving Average	8.13
200-Day Moving Average	20.79
Relative Strength Index (RSI)	44.72
Average Volume (20 Days)	130,429

Short Selling Information

The latest short interest is 399,525, so 8.01% of the outstanding shares have been sold short.

Short Interest	399,525
Short Previous Month	7.92M
Short % of Shares Out	8.01%
Short % of Float	10.64%
Short Ratio (days to cover)	3.03

Income Statement

In the last 12 months, MRSN had revenue of $34.77 million and -$74.04 million in losses. Loss per share was -$14.95.

Revenue	34.77M
Gross Profit	-38.25M
Operating Income	-71.97M
Pretax Income	-134.81M
Net Income	-74.04M
EBITDA	-70.54M
EBIT	-71.97M
Loss Per Share	-$14.95

Full Income Statement

Balance Sheet

The company has $102.29 million in cash and $24.62 million in debt, giving a net cash position of $77.66 million or $15.58 per share.

Cash & Cash Equivalents	102.29M
Total Debt	24.62M
Net Cash	77.66M
Net Cash Per Share	$15.58
Equity (Book Value)	-30.87M
Book Value Per Share	-6.19
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is -110.01%, with operating and profit margins of -206.99% and -212.94%.

Gross Margin	-110.01%
Operating Margin	-206.99%
Pretax Margin	-211.74%
Profit Margin	-212.94%
EBITDA Margin	-202.87%
EBIT Margin	-206.99%
FCF Margin	n/a

Dividends & Yields

MRSN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.12%
Shareholder Yield	-2.12%
Earnings Yield	-218.08%
FCF Yield	n/a

Analyst Forecast

The average price target for MRSN is $143.75, which is 2,010.87% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$143.75
Price Target Difference	2,010.87%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	54.29%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 28, 2025. It was a reverse split with a ratio of 1:25.

Last Split Date	Jul 28, 2025
Split Type	Reverse
Split Ratio	1:25

Scores

Altman Z-Score	n/a
Piotroski F-Score	1